Drogas potenciadoras para la búsqueda de la perfección

McVeigh, Jim; Evans-Brown, Michael; Bellis, Mark A

doi:10.20882/adicciones.88

Cited by 44 publications

(17 citation statements)

References 6 publications

(6 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Typically, they are not consumed either for a treatment of an illness or injury nor for instant gratification through their psychoactive properties. Instead, their function is an attempt to change an individual’s appearance or improve a skill, ability or activity [1, 2]. Characterised by man’s endeavour to gain an advantage over his competitor, their usage is by no means a new phenomenon, featured in social, ritual and sporting contexts throughout recorded history.…”

Section: Introductionmentioning

confidence: 99%

Treatments for people who use anabolic androgenic steroids: a scoping review

et al. 2019

Self Cite

View full text Add to dashboard Cite

Background: A growing body of evidence suggests that anabolic androgenic steroids (AAS) are used globally by a diverse population with varying motivations. Evidence has increased greatly in recent years to support understanding of this form of substance use and the associated health harms, but there remains little evidence regarding interventions to support cessation and treat the consequences of use. In this scoping review, we identify and describe what is known about interventions that aim to support and achieve cessation of AAS, and treat and prevent associated health problems.Methods: A comprehensive search strategy was developed in four bibliographic databases, supported by an iterative citation searching process to identify eligible studies. Studies of any psychological or medical treatment interventions delivered in response to non-prescribed use of AAS or an associated harm in any setting were eligible. Results: In total, 109 eligible studies were identified, which included case reports representing a diverse range of disciplines and sources. Studies predominantly focussed on treatments for harms associated with AAS use, with scant evidence on interventions to support cessation of AAS use or responding to dependence. The types of conditions requiring treatment included psychiatric, neuroendocrine, hepatic, kidney, cardiovascular, musculoskeletal and infectious. There was limited evidence of engagement with users or delivery of psychosocial interventions as part of treatment for any condition, and of harm reduction interventions initiated alongside, or following, treatment. Findings were limited throughout by the case report study designs and limited information was provided.Conclusion: This scoping review indicates that while a range of case reports describe treatments provided to AAS users, there is scarce evidence on treating dependence, managing withdrawal, or initiating behaviour change in users in any settings. Evidence is urgently required to support the development of effective services for users and of evidence-based guidance and interventions to respond to users in a range of healthcare settings. More consistent reporting in articles of whether engagement or assessment relating to AAS was initiated, and publication within broader health-or drug-related journals, will support development of the evidence base.

show abstract

Section: Introductionmentioning

confidence: 99%

Treatments for people who use anabolic androgenic steroids: a scoping review

et al. 2019

Self Cite

View full text Add to dashboard Cite

show abstract

“…This may account, in some ways, for the diversity of motivations and patterns of AAS use observed in the contemporary AAS using population; social media and online forums have provided new ways of sharing information about the use of substances and displaying their effects on the body. The growth of the internet and developments in global transportation combined with low cost manufacturing has increased availability, ease of access and affordability of these drugs {Brennan, Wells andVan Hout, 2017} (Evans-Brown, Kimergård, &McVeigh, 2009;McVeigh, Evans-Brown, & Bellis, 2012).…”

Section: Introductionmentioning

confidence: 99%

Identifying a typology of men who use anabolic androgenic steroids (AAS)

Zahnow

McVeigh

Bates

et al. 2018

International Journal of Drug Policy

Self Cite

View full text Add to dashboard Cite

Identifying a typology of men who use Anabolic Androgenic Steroids (AAS)http://researchonline.ljmu.ac.uk/8081/ Article LJMU has developed LJMU Research Online for users to access the research output of the University more effectively. Copyright © and Moral Rights for the papers on this site are retained by the individual authors and/or other copyright owners. Users may download and/or print one copy of any article(s) in LJMU Research Online to facilitate their private study or for non-commercial research. You may not engage in further distribution of the material or use it for any profit-making activities or any commercial gain.The version presented here may differ from the published version or from the version of the record. Please see the repository URL above for details on accessing the published version and note that access may require a subscription.

show abstract

“…Yet, the demand for lifestyle medicines, including illicit products, continues to rise, as does the range of pills and products that claim the ability to improving one's lifestyle and human attributes (McVeigh et al, 2012). In case these medicines are sold on the illicit market, lifestyle medicines are also often referred to as human enhancement drugs and can generally be divided into six different categories: i) muscle drugs, such as anabolic-androgenic steroids; ii) weight-loss drugs, such as ephedrine and Sibutramine; iii) skin and hair enhancing drugs, such as Melanotan); iv) sexual enhancers, such as sildenafil; v) cognitive enhancers, such as methylphenidate); vi) and mood and behavior enhancers, such as beta-blockers (Evans-Brown et al, 2012;van de Ven, 2016).…”

Section: Illicit Lifestyle Medicinesmentioning

confidence: 99%

“…Consumer culture is related to the ideal beauty, to perfection and to pursuit of increased happiness. The category 'human enhancement drugs' includes not only drugs that affect beauty, but also those that claim to improve cognitive abilities, social capabilities or sexual competence (McVeigh et al, 2012). Katz and Marshall (2003) highlight how media and marketing discourses increasingly portray older people as independent, sexy and 'ageless' seniors, and seek to stimulate these potential customers to take control of their own sexual wellbeing.…”

Section: Sociology Of Health: Identity and Medicalizationmentioning

confidence: 99%

The illicit medicines trade from within An analysis of the demand and supply sides of the illicit market for lifestyle medicines

Koenraadt¹

2017

View full text Add to dashboard Cite

show abstract

Drogas potenciadoras para la búsqueda de la perfección

Cited by 44 publications

References 6 publications

Treatments for people who use anabolic androgenic steroids: a scoping review

Treatments for people who use anabolic androgenic steroids: a scoping review

Identifying a typology of men who use anabolic androgenic steroids (AAS)

The illicit medicines trade from within An analysis of the demand and supply sides of the illicit market for lifestyle medicines

Contact Info

Product

Resources

About